Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6421 to 6435 of 8314 results

  1. AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35)

    This advice has been updated and replaced by NICE medtech innovation briefing 232.

    Medtech innovation briefing
    Published
    5 August 2015

  2. Self-harm in over 8s: short-term management and prevention of recurrence (CG16)

    This guidance has been updated and replaced by NICE guideline NG225.

    Clinical guideline
    Published
    28 July 2004

  3. Fever in under 5s: assessment and initial management (CG160)

    This guidance has been updated and replaced by NICE guideline NG143.

    Clinical guideline
    Published
    22 May 2013

  4. Stroke rehabilitation in adults (CG162)

    This guidance has been updated and replaced by NICE guideline NG236.

    Clinical guideline
    Published
    12 June 2013

  5. Familial breast cancer (CG14)

    This guidance has been updated and replaced by NICE guideline CG41.

    Clinical guideline
    Published
    23 May 2004

  6. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

    This guidance has been updated and replaced by NICE guideline NG158.

    Clinical guideline
    Published
    27 June 2012

  7. Clostridium difficile infection: fidaxomicin (ESNM1)

    This advice has been updated and replaced by NICE guideline NG199.

    Evidence summary
    Published
    13 July 2012

  8. Type 2 diabetes: lixisenatide (ESNM10)

    This evidence summary has been updated and replaced by NICE advice ESNM26.

    Evidence summary
    Published
    18 January 2013

  9. Acute diarrhoea in adults: racecadotril (ESNM11)

    This evidence summary has been withdrawn because the product is no longer available in the UK.

    Evidence summary
    Published
    12 March 2013

  10. Acute diarrhoea in children: racecadotril as an adjunct to oral rehydration (ESNM12)

    This evidence summary has been withdrawn because the product is no longer available in the UK.

    Evidence summary
    Published
    12 March 2013

  11. Non-cystic fibrosis bronchiectasis: inhaled tobramycin (ES12)

    This evidence summary has been updated and replaced by NICE guideline NG117.

    Evidence summary
    Published
    4 April 2017

  12. Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates (ES15)

    This evidence summary has been updated and replaced by NICE guideline NG101.

    Evidence summary
    Published
    25 July 2017

  13. Chronic obstructive pulmonary disease: beclometasone, formoterol and glycopyrronium (Trimbow) (ES17)

    This evidence summary has been updated and replaced by NICE guideline 115.

    Evidence summary
    Published
    3 May 2018

  14. Oestrogen deficiency symptoms in postmenopausal women: conjugated oestrogens and bazedoxifene acetate (ES3)

    This evidence summary has been withdrawn because the product is no longer available in the UK.

    Evidence summary
    Published
    22 December 2016

  15. Antimicrobial prescribing: cefiderocol (ES31)

    This evidence summary has been updated and replaced by NICE antimicrobial health technology evaluation guidance on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.

    Evidence summary
    Published
    2 December 2020